Strauss Borrelli PLLC, a leading data breach law firm, is investigating Genentech, Inc. regarding its recent data breach. The Genentech data breach involved sensitive personal identifiable information and protected health information belonging to an undetermined number of individuals.
ABOUT GENENTECH, INC.:
Genentech is a biotechnology company based in California. Founded in 1976, Genentech is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.3 Now a member of the Roche Group, Genentech’s transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.3 Headquartered in San Francisco, California, Genentech employs over 10,000 individuals.
WHAT HAPPENED?
Recently, Genentech was informed that its business partner, Cencora, Inc., and its Lash Group affiliate had experienced a data breach in which sensitive protected health information belonging to Genentech customers in its systems may have been accessed and acquired. Through its investigation, Cencora determined that an unauthorized actor gained access to this sensitive information on February 21, 2024. On May 20, 2024, Cencora began notifying individuals whose information may have been impacted. The type of information potentially exposed includes:
- Name
- Date of birth
- Address
- Medical information (e.g., health diagnosis, and/or medications and prescriptions)
If you received a breach notification letter from Genentech, Inc., Cencora, Inc. or The Lash Group:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
